Journal
AUSTRALIAN PRESCRIBER
Volume 41, Issue 3, Pages 60-63Publisher
NATL PRESCRIBING SERVICE LTD
DOI: 10.18773/austprescr.2018.022
Keywords
anticonvulsants; antidepressants; cannabinoids; neuropathic pain; opioids
Categories
Ask authors/readers for more resources
Neuropathic pain is relatively common and often poorly treated. Management options include tricyclic antidepressants or serotonin and noradrenaline reuptake inhibitors in the first instance, followed by pregabalin or gabapentin. Tramadol or topical lidocaine (lignocaine) could be considered as second line. Stronger opioids have been relegated to third line. It is important to remember that opioids and gabapentinoids have abuse potential. Fibromyalgia and chronic low back pain without radiculopathy do not meet the current criteria for the definition of neuropathic pain.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available